Preliminary evidences of a possible correlation between anti-phospholipid antibodies and coagulopathy in COVID-19 patients derived from Zhang et al., who reported three cases with thrombosis, aCL, and aβ2GP1 positivity only for IgA class [13]. This evidence concerns the gene CD79A and Venous thrombosis.